Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database-Reference-Cited by-同舟云学术

Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database

Published:2009-11 Issue:11 Volume:31 Page:2653-2664
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Pelletier Elise M.,Ogale Sarika,Yu Elaine,Brunetta Paul,Garg Jay

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data;Chakravarty;Arthritis Rheum.,2007

2. Investigation of systemic lupus erythematosus in Nogales, Arizona;Balluz;Am J Epidemiol.,2001

3. Accrual of organ damage over time in patients with systemic lupus erythematosus;Gladman;J Rheumatol.,2003

4. Lupus nephritis;Cameron;J Am Soc Nephrol.,1999

5. SLE patients with renal damage incur higher health care costs;Clarke;Rheumatology (Oxford).,2008

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical management of lupus in the United States: A claims-based analysis;Seminars in Arthritis and Rheumatism;2024-10

2. Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study;Value in Health Regional Issues;2024-09

3. Costo de atención hospitalaria en pacientes con lupus eritematoso sistémico en un hospital de alta complejidad en Colombia;Revista Colombiana de Reumatología;2024-08

4. Healthcare resource utilization and costs in patients with a newly confirmed diagnosis of lupus nephritis in the United States over a 5-year follow-up period;BMC Health Services Research;2024-05-31

5. Characterization of the patterns of care, access, and direct cost of systemic lupus erythematosus in Brazil: findings from the Macunaíma study;Advances in Rheumatology;2024-04-19